Our findings that RelA ablation delayed the onset and growth of SCLC resulting in considerably prolonged mouse survival provided experimental evidence that RelA-dependent NF-κB-dependent gene transcription also plays an important role in SCLC. The gene discussed is NFKB1; the disease is small cell lung carcinoma.